Skip to content

Clinical trials

Muscular Dystrophy, Duchenne trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Country / region: Israel Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20081
20091
20101
20111
20121
20131
20141
20151
20164
20173
20184
20202
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Terminated7
Active, not recruiting3
No longer available1
Recruiting1
Unknown status1
Available1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PTC Therapeutics6
ReveraGen BioPharma, Inc.4
Santhera Pharmaceuticals3
Sarepta Therapeutics, Inc.3
Cooperative International Neuromuscular Research Group2
Edgewise Therapeutics, Inc.2
GlaxoSmithKline2
Italfarmaco2
BioMarin Pharmaceutical1
Catabasis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne29
Muscular Dystrophies7
Musculoskeletal Diseases3
Neuromuscular Diseases3
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Muscular Diseases2
Muscular Disorders, Atrophic2
Nervous System Diseases2

Trials

Showing 51 to 29 of 29. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.